A. Viral Properties
- Discovered in mid-1970s (serologic reaction in plate B, position 19)
- Member of Parvoviridae Family
- Mainly pathogenic animal viruses
- Parvovirus B19 is the only human disease-causing member
- Adenoassociated viruses (AAV) infect humans but do not cause disease
- Feline panleukopenia virus
- Canine parvovirus
- Aleutian mink disease virus
- Porcine parvovirus
- Parvum = "Small"
- 25nm diameter virus
- Single stranded DNA virus, ~5600 nucleotides
- Single promoter of virus genome
- Nonstructural protein NS1, has replicative functions and is cytotoxic to host cells
- Two structural proteins VP1 and VP2
- Cell Surface Receptor
- Cell surface receptor is globoside 4 (Gb4), also called P antigen
- Gb4 primarily expressed on erythrocyte precursors
- Gb4 also expressed on granulocytes, platelets, heart, lung, liver, kidney, synovial cells
B. Human Infection
- Usually occurs in childhood but also presents in adults
- Nearly all persons have been infected by the time they are elderly
- ~50% of 15 year olds have parvovirus IgG antibodies
- Infections usually occur in the spring
- Incubation period 6-18 days
- Usually asymptomatic
- Childhood Infection
- Rash is most common symptom, particularly in children
- "Slapped cheek" appearance, mainly in children, is erythema infectiosum, "Fifth Disease"
- Red maculopapular rash with lace-like reticular pattern, usually on extremities
- Transient erythroblastopenia of childhood
- Adult Infection
- Adults usually present with influenza-like illness, typically without facial rash
- May present with severe influenza-syndrome
- Pancytopenia may occur with associated symptoms
- Rare aplastic anemia and other bone marrow failure syndromes
- Fetal complications
- Immunological dysfunction including autoimmunity
- May present with polyarthritis, malaise, fever [2]
- May present with lupus-like syndrome (including anti-dsDNA antibodies) [8]
- Arthralgias and Frank Polyarthritis [2]
- May cause acute or chronic arthropathy
- Polyarthritis usually symmetric involving both large and small joints
- May resemble rheumatoid arthritis, but is usually self-limited
- Unclear whether virus actually plays role in chronic disease [3]
- May present with lupus-like syndrome and antinuclear ± anti-dsDNA antibodies [8]
C. Other Associated Conditions
- Immune thrombocytopenia
- Aplastic Crisis [4]
- Especially in hemoglobinopathies: sickle cell disease [6], spherocytosis
- Immunosuppressed patients, including organ transplant recipients
- Infection During Pregnancy [5]
- May increase risk of fetal death (see below)
- Most often contracted from exposure to mother's household children
- Nursery school teachers also have increased risk
- Hydrops fetalis
- Can be confused with Blackfan-Diamond Anemia
- Intrauterine Fetal Death [7]
- 15% of cases of late fetal death positive for parvovirus B19 DNA
- 0% of cases of normal pregnancy at term had parvovirus DNA
- 5% of miscarriages but none of the cases of induced abortion had parovirus DNA
- Chronic Anemia
- Relationship to Rheumatologic Disorders
- May induce anti-nuclear and even anti-dsDNA antibodies [8]
- Some association with rheumatoid factor and rheumatoid arthritis (viral arthritis)
- Polyarteritis Nodosum (PAN)
- Acute myocarditis
- Encephalitis (aseptic meningitis)
- Brachial Plexus Neuropathy
D. Diagnosis
- ~50% of adults have IgG Antibody (Ab)
- Acute infection - increases in IgM Ab in 3-4 weeks have IgM Ab
- May induce positive antinuclear antibody (ANA) or positive anti-dsDNA antibody
- DNA hybridization / polymerase chain reaction very sensitive
E. Treatment
- No specific anti-viral agents are available
- Intravenous immune globulin (IVIg) contains good levels of anti-B19 antibodies
- May be used for persistent infections
- Treat with 5-10 day course of IVIG 0.4gm/kg daily
- Arthropathy
- Non-steroidal anti-inflammatory drugs (NSAIDs)
- Glucocorticoids - oral prednisone 40mg qd with rapid taper will reduce symptoms
- Special concern: pregnancy, immunodeficiency, red cell disorder
- Vaccine is being developed
F. Risk in Pregnancy
- May cause fetal hydrops, which can be fatal
- Low but definite risk to fetus in women exposed to virus
- Can also cause late stage intrauterine fetal death (see above)
- Test for IgM anti-parvovirus Ab
- Follw high risk patients with ultrasound, AFP levels (both unproven to affect outcome)
- Consider termination of pregnancy
References
- Young NS and Brown KE. 2004. NEJM. 350(6):586
- Martin DP, Schlott DW, Flynn JA. 2007. NEJM. 357(18):1856 (Case Discussion)
- Soderlund M, von Essen R, Haapasaari J, et al. 1997. Lancet. 349:1063
- Abbey E and Lacy J. 1998. Am J Med. 104(2):200 (Case Record)
- Valeur-Jensen AK, Pedersen CB, Westergaard T, et al. 1999. JAMA. 281(12):1099
- Steinberg MH. 1999. NEJM. 340(13):1021
- Tolfvenstam T, Papadogiannakis N, Norbeck O, et al. 2001. Lancet. 357(9267):1494
- Garcia FJN, Domingo-Domenech E, Castro-Bohorquez FJ, et al. 2001. Am J Med. 111(7):573